Madaras-Kelly Karl J, Boyd Jeremy K, Bond Laura
College of Pharmacy, Idaho State University, Meridian, ID.
Boise VA Medical Center, Boise, ID.
Medicine (Baltimore). 2025 Jul 18;104(29):e43172. doi: 10.1097/MD.0000000000043172.
Studies of urinary tract infection (UTI) treatment in telehealth settings have primarily evaluated young, healthy females. Urine culture collection is less common in telehealth settings but is recommended for all patients with potentially complicated infection. The aims of this study were: (1) to compare UTI-related clinical failure between telehealth and in-person primary care settings, and (2) evaluate if urine culture (UC) collection impacted UTI-related failure in patients with risk for antibiotic resistant infection. A retrospective cohort study of outpatients diagnosed with UTI between 2019 and 2021 in the Department of Veterans Affairs system was conducted. Inclusion required a telehealth or primary care visit with UTI International Classification of Diseases-Clinical Modification 10th revision code documentation and an antibiotic dispensed. Patients with recent UTI, concurrent indications for antibiotics, or where asymptomatic bacteriuria treatment was appropriate were excluded. Treatment failure was defined as combination of a new UTI-related outpatient visit or hospitalization that occurred between 3 to 30 days after the antibiotic dispense date. Antibiotic exposure data, covariates, hospitalization, and UC history were obtained. Overlap weighting and generalized estimating equation models estimated the relative risk of failure for clinical setting and for UC collection versus no collection. There were 16,266 telehealth and 29,296 primary care patient-visits evaluated. The adjusted relative risk (±95% CI) of failure for telehealth relative to primary care was [0.87 (0.70, 1.08)]. An interaction between setting and age ≥65 [1.45 (1.12, 1.87)] indicated higher failure for elderly patients treated for UTI in telehealth. Urine culture collection was associated with increased risk of failure for patients treated in telehealth [2.06 (1.56, 2.72)]; however, an interaction between UC collection and prior antibiotic exposure ≤90 days indicated a protective effect in both telehealth [0.70 (0.53, 0.93)] and primary care [0.77 (0.60, 0.99)] settings. Overall, no difference in the clinical failure rate for UTI treatment between telehealth and primary care was observed. However, elderly patients treated for UTI in telehealth experienced higher failure relative to in-person primary care. Patients with recent prior antibiotic exposure in both settings had lower clinical failure rates when UCs were collected.
远程医疗环境下尿路感染(UTI)治疗的研究主要评估了年轻、健康的女性。在远程医疗环境中,尿液培养采集不太常见,但建议对所有可能患有复杂性感染的患者进行采集。本研究的目的是:(1)比较远程医疗和面对面初级保健环境中与UTI相关的临床治疗失败情况;(2)评估尿液培养(UC)采集是否会影响有抗生素耐药感染风险患者的UTI相关治疗失败情况。对2019年至2021年在退伍军人事务部系统中诊断为UTI的门诊患者进行了一项回顾性队列研究。纳入标准要求有远程医疗或初级保健就诊记录,且有UTI国际疾病分类第十次修订版临床修正代码记录以及已配发抗生素。排除近期患有UTI、有同时使用抗生素指征或适合进行无症状菌尿治疗的患者。治疗失败定义为在抗生素配发日期后3至30天内发生的与新的UTI相关的门诊就诊或住院治疗。获取了抗生素暴露数据、协变量、住院情况和UC病史。重叠加权和广义估计方程模型估计了临床环境以及UC采集与未采集情况下治疗失败的相对风险。共评估了16266次远程医疗患者就诊和29296次初级保健患者就诊。远程医疗相对于初级保健的调整后失败相对风险(±95%CI)为[0.87(0.70,1.08)]。年龄≥65岁的患者在远程医疗环境中接受UTI治疗时,环境与年龄之间的交互作用[1.45(1.12,1.87)]表明治疗失败率更高。在远程医疗环境中接受治疗的患者,尿液培养采集与治疗失败风险增加相关[2.06(1.56,2.72)];然而,UC采集与之前90天内抗生素暴露之间的交互作用表明,在远程医疗[0.70(0.53,0.93)]和初级保健[0.77(0.60,0.99)]环境中均有保护作用。总体而言,未观察到远程医疗和初级保健在UTI治疗临床失败率上的差异。然而,与面对面初级保健相比,在远程医疗环境中接受UTI治疗的老年患者治疗失败率更高。在两种环境中,近期有抗生素暴露史的患者在采集UC时临床失败率较低。